home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Understanding The Development Of Secondary Tumours

  July, 2 2002 1:27
your information resource in human molecular genetics
Metastasis is a multistep process in which cancer cells grow, become mobile, and disseminate, thereby leading to the development of secondary tumours at a distance from the original tumour. Understanding the mechanisms of metastasis is essential if we are to develop ways to block the formation of secondary tumours. Reporting in the July issue of Nature Cell Biology, Allan Balmain and colleagues at the University of California in San Francisco show that increasing the activation levels of the signalling molecules Smad2 and H-ras sequentially drives tumours through the different stages of becoming metastatic.

The TGF-beta and H-ras signalling pathways had previously been implicated in tumour progression. Now Oft et al. show that activating Smad2, one protein that works with TGF-beta, is sufficient to induce migration of tumour cells. Increasing the amount of H-ras is required, in addition to Smad2 activation, to drive resident epithelial-like cells to develop into mobile fibroblastoid-like cells. A further increase in Smad2 levels in these fibroblastoid-like cancer cells allows them to enter blood vessels and travel to other tissues. These findings have far-reaching implications for preventing secondary-tumour development.

Author contact:
Dr Allan Balmain
Cancer Research Institute
University of California
San Francisco, CA, USA
Tel: +1 415 502 4192
E-mail: abalmain@cc.ucsf.edu

(C) Nature Cell Biology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.